A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026] |
Wexler, Leonard |
- Sarcomas
- Rhabdomyosarcoma
- Soft Tissue Sarcoma
|
A Phase I Study of Axitinib plus Dalantercept for Patients with Metastatic Kidney Cancer
[Protocol 12-255] |
Voss, Martin |
|
A Phase I Study of BMS-936558 in Combination with Sunitinib or Pazopanib in Patients with Metastatic Renal Cell Carcinoma
[Protocol 12-147] |
Voss, Martin |
|
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023] |
Van Zee, Kimberly |
|
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096] |
Trippett, Tanya |
|
A Phase I Study of AC220 for Children with Relapsed or Refractory Acute Leukemias
[Protocol 12-141] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139] |
Trippett, Tanya |
- Hepatobiliary
- Kidney Cancer
- Sarcomas
- Thyroid Cancer
|
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] |
Trippett, Tanya |
- Neuroblastoma
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Soft Tissue Sarcoma
|
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] |
Trippett, Tanya |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] |
Trippett, Tanya |
- Pediatric Brain Tumors
- Primary Bone
- Sarcomas
- Solid Tumors
|
A Phase I Study of Plerixafor as a Chemosensitizing Agent for Children with Relapsed Acute Leukemia or Myelodysplastic Syndromes
[Protocol 11-208] |
Trippett, Tanya |
- Hematology
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
|
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase II Study of Abraxane with or without Tigatuzumab in Patients with Metastatic Triple-Negative Breast Cancer
[Protocol 11-082] |
Traina, Tiffany |
|
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190] |
Traina, Tiffany |
|
A Phase I Study of Enzalutamide (MDV3100) in Patients with Previously Treated Metastatic Breast Cancer
[Protocol 12-155] |
Traina, Tiffany |
|
A Phase II Study of Abiraterone, Exemestane, or Both in Postmenopausal Women with ER-Positive Metastatic Breast Cancer
[Protocol 12-140] |
Traina, Tiffany |
|
Prospective Ascertainment for Late Effects Among Cancer Survivors
[Protocol 12-143] |
Tonorezos, Emily |
|
A Phase II Study of MLN8237 (Alisertib) with Paclitaxel versus Paclitaxel Alone in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-100] |
Tew, William |
|
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104] |
Tew, William |
- Geriatrics
- Ovarian Cancer
|
